Literature DB >> 19281675

Managing multiple sclerosis in primary care: are we forgetting something?

George A Jelinek1, Craig S Hassed.   

Abstract

Multiple sclerosis (MS) is the commonest debilitating, progressive neurological disorder in most Western countries. It is important for many reasons, including the personal costs, levels of disability produced, age group affected and the resultant economic burden placed on individuals, families and the community. Although it is thought to be an autoimmune condition, in general little is understood about the causation of MS and the factors that trigger or contribute to exacerbations and deterioration. This overview of the literature will consider some important studies examining the relationship between lifestyle and psychosocial factors and MS progression. These studies suggest that nutrition, sunlight, exercise, stress and social factors can all modulate the rate of progression of MS and the level of disability. Although appearing in respected journals, this information tends to be little known or discussed by clinician and patient alike. If lifestyle approaches do offer potential avenues for therapy, this raises important questions regarding the management of MS in primary care. More widely prescribed conventional medicines have been studied in more detail but are only modestly effective and may have significant side-effects. Are we presently neglecting the most effective approach of combining the non-drug or holistic approach with the best of conventional pharmaceutical therapies, and if so what are the implications of this omission?

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19281675

Source DB:  PubMed          Journal:  Qual Prim Care        ISSN: 1479-1064


  9 in total

Review 1.  Vaccination against infection in patients with multiple sclerosis.

Authors:  Micha Loebermann; Alexander Winkelmann; Hans-Peter Hartung; Hartmut Hengel; Emil C Reisinger; Uwe K Zettl
Journal:  Nat Rev Neurol       Date:  2012-01-24       Impact factor: 42.937

2.  Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis.

Authors:  Emily J Hadgkiss; George A Jelinek; Tracey J Weiland; Greg Rumbold; Claire A Mackinlay; Siegfried Gutbrod; Ian Gawler
Journal:  Neurol Sci       Date:  2012-02-25       Impact factor: 3.307

3.  Engagement in a program promoting lifestyle modification is associated with better patient-reported outcomes for people with MS.

Authors:  Emily J Hadgkiss; George A Jelinek; Keryn L Taylor; Claudia H Marck; Dania M van der Meer; Naresh G Pereira; Tracey J Weiland
Journal:  Neurol Sci       Date:  2015-02-01       Impact factor: 3.307

4.  The effects of a mindfulness-based lifestyle programme for adults with Parkinson's disease: protocol for a mixed methods, randomised two-group control study.

Authors:  Jenny Advocat; Grant Russell; Joanne Enticott; Craig Hassed; Jennifer Hester; Brooke Vandenberg
Journal:  BMJ Open       Date:  2013-10-10       Impact factor: 2.692

5.  Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics.

Authors:  Emily J Hadgkiss; George A Jelinek; Tracey J Weiland; Naresh G Pereira; Claudia H Marck; Dania M van der Meer
Journal:  Neurol Res Int       Date:  2013-04-11

6.  Association of fish consumption and Ω 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis.

Authors:  George A Jelinek; Emily J Hadgkiss; Tracey J Weiland; Naresh G Pereira; Claudia H Marck; Dania M van der Meer
Journal:  Int J Neurosci       Date:  2013-06-03       Impact factor: 2.292

7.  Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study.

Authors:  George A Jelinek; Alysha M De Livera; Claudia H Marck; Chelsea R Brown; Sandra L Neate; Keryn L Taylor; Tracey J Weiland
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

8.  The effects of a mindfulness-based lifestyle program for adults with Parkinson's disease: a mixed methods, wait list controlled randomised control study.

Authors:  Jenny Advocat; Joanne Enticott; Brooke Vandenberg; Craig Hassed; Jennifer Hester; Grant Russell
Journal:  BMC Neurol       Date:  2016-09-08       Impact factor: 2.474

9.  Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study.

Authors:  Amanda K Irish; Constance M Erickson; Terry L Wahls; Linda G Snetselaar; Warren G Darling
Journal:  Degener Neurol Neuromuscul Dis       Date:  2017-01-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.